Skip to Main Content

Paper Details

Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
Annals of Surgery
18
2022
NAT, PDO, PDO cultures, PDOs, Pancreatic Cancer, Patient, oxaliplatin, pancreatic adenocarcinoma, pancreatic cancer, patient, patients
Author NameAffiliation
Peter K GregersenInstitute of Molecular Medicine, Feinstein Institutes for Medical Research
  • 1 - 1

Datasets

Release 1.2